| Structure | Chemical Name | CAS | MF |
|
Ethanone, 1-[4,5-dihydro-5-(hydroxymethyl)-2-methyl-3-furanyl]- (9CI)
|
202336-17-2
|
C8H12O3
|
|
1H-Pyrazolo[4,3-b]pyridin-3-amine(9CI)
|
202336-32-1
|
C6H6N4
|
|
1,2-Benzisoxazole,3a,4,5,7a-tetrahydro-3-methoxy-,(3aR-cis)-(9CI)
|
202339-44-4
|
C8H11NO2
|
|
3-Cyclohexene-1-carboxylicacid,2-hydroxy-,methylester,(1R-cis)-(9CI)
|
202339-45-5
|
C8H12O3
|
|
EFLUCIMIBUM
|
202340-45-2
|
C29H43NO2S
|
|
1,1-dioxidotetrahydro-3-thienyl diphenylphosphinate
|
202341-88-6
|
C16H17O4PS
|
|
1,1-dioxido-2,3-dihydro-3-thienyl diphenyl phosphate
|
202341-90-0
|
C16H15O6PS
|
|
Dasycarpol
|
202343-57-5
|
C14H16O4
|
|
BOC-PNA-D(Z)-OH
|
202343-73-5
|
C24H30N8O7
|
|
1H-Pyrrolo[1,2-a]benzimidazole,2,3-dihydro-2,2-dimethyl-(9CI)
|
202346-19-8
|
C12H14N2
|
|
Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro-3,3-dimethyl- (9CI)
|
202346-20-1
|
C13H16N2
|
|
4H-1,2-Oxazin-4-amine,6-ethoxy-5,6-dihydro-3-phenyl-,trans-(9CI)
|
202347-47-5
|
C12H16N2O2
|
|
Imidazo[1,2-a]pyridine-2-carboxaldehyde, 7-methyl- (9CI)
|
202348-54-7
|
C9H8N2O
|
|
Imidazo[1,2-a]pyridine-2-carboxaldehyde, 6-methyl- (9CI)
|
202348-55-8
|
C9H8N2O
|
|
1H-Pyrrole-2-carboxylic acid, 3-acetyl-, methyl ester (9CI)
|
202348-85-4
|
C8H9NO3
|
|
Ethanone, 1-(4-nitro-1H-pyrrol-3-yl)- (9CI)
|
202348-96-7
|
C6H6N2O3
|
|
(S)-FluMequine
|
202349-45-9
|
C14H12FNO3
|
|
N-(4-bromophenyl)-2-((3-cyano-4-(naphthalen-1-yl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl)thio)acetamide
|
202349-83-5
|
C24H18BrN3O2S
|
|
PNU-159682
|
202350-68-3
|
C32H35NO13
|
|
2-Pyrimidinecarboxylic acid, 4,6-dimethoxy-, methyl ester (9CI)
|
202350-72-9
|
C8H10N2O4
|
|
4-Hexenoicacid,2-amino-2-methyl-,[R-(E)]-(9CI)
|
202351-49-3
|
C7H13NO2
|
|
D-Alanine, 3-cyano-2-methyl- (9CI)
|
202351-51-7
|
C5H8N2O2
|
|
Siloxanes and Silicones, di-Me, polymers with Ph silsesquioxanes, methoxy- and (trimethylsilyl)oxy-terminated, polymers with adipic acid, ethylene glycol, isophthalic acid and trimethylolpropane
|
202352-14-5
|
|
|
1H-Imidazol-2-amine,4,5-dihydro-4,5-dimethoxy-,trans-(9CI)
|
202391-52-4
|
C5H11N3O2
|
|
5-(3-Aminopropyl)-1H-imidazol-2-amine
|
202391-71-7
|
C6H12N4
|
|
2-BROMOBUTANE-D9
|
202392-72-1
|
C4BrD9
|
|
Spiro[bicyclo[3.2.0]hept-6-ene-2,2-[1,3]dioxolane]
|
202393-37-1
|
C9H12O2
|
|
Benzothiazole, 2-(chlorodifluoromethyl)- (9CI)
|
202396-46-1
|
C8H4ClF2NS
|
|
Benzothiazole, 2-(chloromethyl)-7-fluoro- (9CI)
|
202396-51-8
|
C8H5ClFNS
|
|
6-chloro-2-(chloromethyl)-1,3-benzoxazole
|
202396-52-9
|
C8H5Cl2NO
|
|
2-Thiophenecarbonyl chloride, 3-(difluoromethoxy)- (9CI)
|
202400-93-9
|
C6H3ClF2O2S
|
|
Imidazo[1,5,4-de][1,4]benzoxazin-2-amine, 4,5-dihydro- (9CI)
|
202403-42-7
|
C9H9N3O
|
|
1H-1,2,4-Triazol-3-amine,5-(1,1-dimethylethyl)-(9CI)
|
202403-45-0
|
C6H12N4
|
|
Octyl D-Galactofuranoside
|
202403-49-4
|
C14H28O6
|
|
L-Tryptophan-13C11,15N2
|
202406-50-6
|
C11H12N2O2
|
|
L-LEUCINE (U-13C6)
|
202406-52-8
|
C6H13NO2
|
|
|
15N2, 99%)
|
202406-87-9
|
H2NCOCH2CH(NH2)COOH·H2O
|
|
|
L-Cysteine-13C3, 15N
|
202406-97-1
|
HSCH2CH(NH2)COOH
|
|
L-4-HYDROXYPHENYLALANINE-13C9,15N
|
202407-26-9
|
C9H11NO3
|
|
L-VALINE-13C5, 15N
|
202407-30-5
|
C5H11NO2
|
|
L-SERINE-13C3, 15N
|
202407-34-9
|
C3H7NO3
|
|
Pyrazinamine, 3-methoxy-5-methyl-, 1-oxide (9CI)
|
202409-04-9
|
C6H9N3O2
|
|
Etoricoxib Impurity 11
|
202409-31-2
|
C17H13ClN2O2S
|
|
Etoricoxib
|
202409-33-4
|
C18H15ClN2O2S
|
|
2-(Benzyloxy)-3-bromo-5-chloropyridine
|
202409-82-3
|
C12H9BrClNO
|
|
Cyclopentene, polymer with 1,3-butadiene, 2-methyl-1,3-butadiene, 2-methyl-1-butene, 3-methyl-1-butene, 1,3-pentadiene and 1-pentene
|
202409-83-4
|
C34H60
|
|
N-[(4-chlorophenyl)phenylMethyl]-ForMaMide
|
202414-68-4
|
C14H12ClNO
|
|
5H-Tetrazol-5-one, 1,2-dihydro-1-(2-oxopropyl)- (9CI)
|
202415-39-2
|
C4H6N4O2
|
|
1H-Pyrrole-2-carboxaldehyde,4-amino-1-methyl-(9CI)
|
202419-38-3
|
C6H8N2O
|
|
Oxo-cyclopentancarbonsure-1-[2-chlor-5-dodecyloxycarbonylanilid]
|
202419-61-2
|
C25H36ClNO4
|
|
1H-Benzotriazole, C-chloro-C-methyl-, sodium salt
|
202420-04-0
|
C7H6ClN3.Na
|
|
|
1,4-Benzenedicarboxylic acid polymer with 3-(dodecenyl)dihydro-2,5-furandione, formaldehyde, 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[ethanol], α,α'-[(1-methylethylidene)di-4,1-phenylene]bis[ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)]], methyloxi
|
202420-33-5
|
|
|
4-Cyclohexene-1,2,3-triol,6-amino-,[1S-(1alpha,2beta,3beta,6beta)]-(9CI)
|
202459-97-0
|
C6H11NO3
|
|
6-[(2-AMINOETHYL)AMINO]NICOTINONITRILE
|
202460-48-8
|
C8H10N4
|
|
1,3-Propanediamine,N-(5-nitro-2-pyridinyl)-(9CI)
|
202460-49-9
|
C8H12N4O2
|
|
Tris(dinaphthoylmethane) mono(phenathroline)europium (III)
|
202460-56-8
|
C69H45EuO6.C12H8N2
|
|
4-(HYDROXYMETHYL)PIPERIDINE-1-CARBOXAMIDINE
|
202462-87-1
|
C7H15N3O
|
|
PG 97-269
|
202463-00-1
|
C150H246N44O38
|
|
1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE
|
202463-68-1
|
C21H19Cl2IN4O2
|
|
(S)-Rasagiline Mesylate
|
202464-88-8
|
C13H17NO3S
|
|
(S)-Rasagiline Mesylate
|
202464-89-9
|
C13H17NO3S
|
|
RO 04-6790
|
202466-68-0
|
C12H16N6O2S
|
|
3-[[[(2S,4S)-4-Mercapto-1-(4-nitrobenzyloxy)carbonyl-2-pyrrolidinyl]carbonyl]amino]benzoic acid
|
202467-69-4
|
C20H19N3O7S
|
|
C4 Dihydroceramide
|
202467-76-3
|
C22H45NO3
|
|
L-ARGININE-13C6, 15N4 HYDROCHLORIDE
|
202468-25-5
|
C6H15ClN4O2
|
|
l-aspartic acid-13c4,15n
|
202468-27-7
|
HO213C13CH213CH(15NH2)13CO2H
|
|
1,2-EPOXYPROPANE-D6
|
202468-69-7
|
C3D6O
|
|
BUTYRIC ACID (D8)
|
202468-80-2
|
C4H8O2
|
|
Benzenemethanamine, N-hydroxy-4-(1-methylethyl)- (9CI)
|
202471-31-6
|
C10H15NO
|
|
Glomeratose A
|
202471-84-9
|
C24H34O15
|
|
L-Proline, 4-amino-3-hydroxy-, (3S,4R)- (9CI)
|
202473-18-5
|
C5H10N2O3
|
|
L-Proline, 4-amino-3-hydroxy-, (3R,4S)- (9CI)
|
202473-21-0
|
C5H10N2O3
|
|
L-Proline, 3-amino-4-hydroxy-, (3R,4R)- (9CI)
|
202473-22-1
|
C5H10N2O3
|
|
N-(3-FLUOROPHENYL)-6,7-DIMETHOXY-4-QUINAZOLINAMINE
|
202475-55-6
|
C16H14FN3O2
|
|
JAK3 INHIBITOR I
|
202475-60-3
|
C16H15N3O3
|
|
N-(3,4-dimethoxyphenyl)-6,7-dimethoxyquinazolin-4-amine
|
202475-65-8
|
C18H19N3O4
|
|
1H-Pyrazole-4-carbonyl chloride, 5-fluoro-1,3-dimethyl- (9CI)
|
202476-26-4
|
C6H6ClFN2O
|
|
(2S,4R)-1-BOC-4-METHANESULFONYLOXY-PROLINE
|
202477-59-6
|
C11H19NO7S
|
|
L-Alanine, 3-amino-, 1,1-dimethylethyl ester (9CI)
|
202477-94-9
|
C7H16N2O2
|
|
N N-DIBENZYL-D-SERINE METHYL ESTER&
|
202478-34-0
|
C18H21NO3
|
|
2-(3-hydroxycyclohexyl)isoindoline-1,3-dione
|
202479-02-5
|
C14H15NO3
|
|
rac-Fluvastatin Methyl Ester (Mixture of diastereoMers)
|
202479-37-6
|
C25H28FNO4
|
|
2,4-D D3
|
202480-67-9
|
C8H3Cl2D3O3
|
|
CHLORAMPHENICOL (D5)
|
202480-68-0
|
C11H7Cl2D5N2O5
|
|
D-[2-2H]RIBOSE
|
202480-69-1
|
C5H9DO5
|
|
EICOSANOIC-20,20,20-D3 ACID
|
202480-70-4
|
C20H37D3O2
|
|
1-BROMOEICOSANE-D41
|
202480-71-5
|
C20BrD41
|
|
1-BROMOEICOSANE-20,20,20-D3
|
202480-72-6
|
C20H38BrD3
|
|
1,2-PROPYLENE-D6 CARBONATE
|
202480-74-8
|
C4D6O3
|
|
2-ETHYLHEXYL-D17 ALCOHOL
|
202480-75-9
|
C8HD17O
|
|
|
Siloxanes and Silicones, di-Me, 3-(4-hydroxy-3-methoxyphenyl)propyl group-terminated, polymers with bisphenol A, carbonic dichloride and 4-(1-methyl-1-phenylethyl)phenol
|
202483-49-6
|
|
|
|
7-Oxa-3,20-diazadispiro5.1.11.2heneicosan-21-one, 2,2,4,4-tetramethyl-, hydrochloride, reaction products with epichlorohydrin, hydrolyzed, polymd.
|
202483-55-4
|
|
|
2-(2-Hexyldecyloxy)benzamide
|
202483-62-3
|
C23H39NO2
|
|
3-Cyclobutene-1,2-dione,3-[(1,1-dimethylpropyl)amino]-4-ethoxy-(9CI)
|
202521-88-8
|
C11H17NO3
|
|
2,4,6-Trimethylbenzylamine / 2,4,6-Trimethylbenzylamine hydrochloride
|
202522-00-7
|
C10H16ClN
|
|
3-Ethyl-4-(hydroxyMethyl)benzonitrile
|
202522-03-0
|
C10H11NO
|
|
Benzonitrile, 3-ethyl-4-formyl- (9CI)
|
202522-04-1
|
C10H9NO
|
|
Benzaldehyde, 2,5-dimethyl-, oxime (9CI)
|
202522-21-2
|
C9H11NO
|
|
4-FLUORO-2-(TRIFLUOROMETHYL)BENZYLAMINE
|
202522-22-3
|
C8H7F4N
|
|
2-CHLORO-5-FLUOROBENZYLAMINE
|
202522-23-4
|
C7H7ClFN
|